Get started
Author

Marianne Levon Shahsuvaryan

Observed names: M L Shahsuvaryan, M Shahsuvaryan, M. L. Shakhsuvaryan, M.L. Shahsuvaryan, ML Shahsuvaryan, Marianne L Shahsuvaryan, Marianne L. Shahsuvaryan, Marianne Shahsuvaryan, MarianneL Shahsuvaryan, Shahsuvaryan Marianne L, Shahsuvaryan, Marianne L
ORCID: 0000-0003-3627-4137
Observed ORCID: 0000-0003-3627-4137
OpenAlex ID: A5058472912
Central Retinal Vein Occlusion Risk Profile: A Case-Control Study
2003 · M.L. Shahsuvaryan, A.K. Melkonyan · European Journal of Ophthalmology · 52
Retinal Vein Occlusion in Armenia
1999 · A. S. Malayan, M. L. Shakhsuvaryan, et al. · European Journal of Ophthalmology · 17
Glaucomatous optic neuropathy management: the role of neuroprotective agents.
2013 · Marianne L Shahsuvaryan · Medical Hypothesis Discovery & Innovation in Ophthalmology · 13
Carbonic anhydrase inhibitors in the management of macular edema: A review of the literature
2022 · Marianne L Shahsuvaryan · Medical Hypothesis Discovery & Innovation in Ophthalmology · 11
PDF
Therapeutic Potential of Ranibizumab in Corneal Neovascularization
2017 · Marianne L. Shahsuvaryan · Trends in Pharmacological Sciences · 11
Therapeutic potential of intravitreal pharmacotherapy in retinal vein occlusion.
2012 · Marianne L Shahsuvaryan · International Journal of Ophthalmology · 8
Evaluation of an AI algorithm trained on an ethnically diverse dataset to screen a previously unseen population for diabetic retinopathy
2024 · Divya P Rao, Florian M Savoy, et al. · Indian Journal of Ophthalmology · 7
Atropine: Updates on myopia pharmacotherapy
2022 · MarianneL Shahsuvaryan · Taiwan Journal of Ophthalmology · 4
Carbonic Anhydrase Inhibitors in Ophthalmology: Glaucoma and Macular Oedema
2021 · Marianne Levon Shahsuvaryan · Progress in drug research · 4
Pharmacovigilance in Intraocular Antiangiogenic Therapy: Shahsuvaryan ML. Ocular impact of intravitreal anti-VEGF
2015 · Marianne L. Shahsuvaryan · International Journal of Ophthalmic Research · 4
PDF
Pharmacological Neuroprotection in Blinding Eye Diseases
2012 · Marianne L. Shahsuvaryan · 4
The Management of Cataract: Where We Are?
2016 · Marianne L. Shahsuvaryan · 3
Pharmacovigilance in intraocular antiangiogenic therapy
2025 · Marianne Levon Shahsuvaryan · Cutaneous and Ocular Toxicology · 2
Systemic Hypertension and the Eye: Highlighting a Comorbidity
2016 · Marianne Shahsuvaryan · Journal of Clinical & Experimental Cardiology · 2
Central Retinal Vein Occlusion: Current Therapeutic Approach
2008 · Marianne L. Shahsuvaryan · Vascular Disease Prevention · 2
Central Retinal Vein Occlusion: Current Therapeutic Approach
2005 · Marianne L. Shahsuvaryan · Vascular Disease Prevention · 2
Update on coronavirus disease and retinal artery occlusion
2025 · Marianne L Shahsuvaryan · Medical Hypothesis Discovery & Innovation in Optometry · 1
Is it time to consider teleophthalmology as a game-changer in the management of diabetic retinopathy?
2023 · Marianne L Shahsuvaryan · Revista Brasileira de Oftalmologia · 1
PDF
Diabetic retinopathy: in need of multi-dimensional pharmacotherapy
2017 · M L Shahsuvaryan · QJM · 1
Age Related Macular Degeneration: Where are we now?
2017 · Marianne L. Shahsuvaryan · 1
Management of Retinal Vein Occlusion, Who Is Responsible?
2016 · Mohamadreza Aghamirsalim, Reza Sorbi, et al. · PubMed · 1
Apoptosis: Current therapeutic approach in retinitis pigmentosa
2012 · Marianne L. Shahsuvaryan · Journal of Physiology and Pathophysiology · 1
Metformin as an Emerging Candidate for Diabetic Retinopathy, Agerelated Macular Degeneration and Glaucoma Pharmacotherapy: Evidence and Perspectives
2026 · Marianne Levon Shahsuvaryan · Current Clinical Pharmacology
Pharmacotherapeutic Challenges of Vascular Endothelial Growth Factor Inhibitors in Retinal Vein Occlusion
2026 · Marianne Levon Shahsuvaryan · ECO SCIENCE JOURNALS
PDF
Ophthalmovigilance in pharmacotherapy of presbyopia
2023 · Marianne Levon Shahsuvaryan · Arquivos Brasileiros de Oftalmologia
PDF
Works count: 55
Citation count: 152
H-index: 7
I10-index: 5
Year
Topic
Type